SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane

Nature Communications

Volumn 3, Issue , 2012, Pages

  Huang, Jian ^a   Yan, Jie ^a   Zhang, Jian ^a   Zhu, Shiguo ^a   Wang, Yanli ^a   Shi, Ting ^a   Zhu, Changhong ^a   Chen, Cheng ^a   Liu, Xin ^a   Cheng, Jinke ^a   Mustelin, Tomas ^b   Feng, Gen Sheng ^c   Chen, Guoqiang ^a   Yu, Jianxiu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SUMO 1 PROTEIN; SUMO1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE FUSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; TUMOR GROWTH; ANIMAL; CELL LINE; CELL TRANSFORMATION; CONFOCAL MICROSCOPY; DRUG SCREENING; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HELA CELL; METABOLISM; MOLECULAR DYNAMICS; PROSTATE TUMOR;

ANIMALS; CELL LINE; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; MALE; MICE; MICROSCOPY, CONFOCAL; MOLECULAR DYNAMICS SIMULATION; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; SUMO-1 PROTEIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863336040     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1919     Document Type: Article

References (41)

1. Das, S., Dixon, J. E. & Cho, W. Membrane-binding and activation mechanism of PTEN. P roc. Natl Acad. Sci. USA 100,7491-7496 (2003). (Pubitemid 36759997)
2. Vazquez, F. et al. Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. P roc. Natl Acad. Sci. USA 103,3633-3638 (2006). (Pubitemid 43376607)
3. Rahdar, M. et al. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. P roc. Natl Acad. Sci. USA 106,480-485 (2009).
4. Lee, J. O. et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99,323-334 (1999).
5. Georgescu, M. M. et al. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res. 60,7033-7038 (2000).
6. Walker, S. M., Leslie, N. R., Perera, N. M., Batty, I. H. & Downes, C. P. Th e tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochem. J. 379,301-307 (2004). (Pubitemid 38570102)
7. Odriozola, L., Singh, G., Hoang, T. & Chan, A. M. Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J. Biol. Chem. 282,23306-23015 (2007).
8. Vazquez, F., Ramaswamy, S., Nakamura, N. & Sellers, W. R. Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell Biol. 20,5010-5018 (2000). (Pubitemid 30431555)
9. Vazquez, F. et al. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J. Biol. Chem. 276,48627-48630 (2001).
10. Yu, J. et al. PTEN regulation by Akt-EGR1-ARF-PTEN axis. E MBO J. 28,21-33 (2009).
11. Palomero, T. et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat. Med. 13,1203-1210 (2007). (Pubitemid 47530629)
12. Chappell, W. H. et al. Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active Notch-1. C ell Cycle 4,1389-1395 (2005). (Pubitemid 41437129)
13. Okumura, K. et al. PCAF modulates PTEN activity. J. Biol. Chem. 281,26562-26568 (2006). (Pubitemid 44401865)
14. Wang, X. et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128,129-139 (2007). (Pubitemid 46048884)
15. Trotman, L. C. et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. C ell 128,141-156 (2007). (Pubitemid 46048885)
16. Maddika, S. et al. WWP2 is an E3 ubiquitin ligase for PTEN. Nat. Cell Biol. 13,728-33 (2011).
17. Lee, S. R. et al. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 277,20336-20342 (2002).
18. Kwak, Y. D. et al. NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. M ol. Neurodegener. 5,49 (2010).
19. Li, Z. et al. Regulation of PTEN by Rho small GTPases. Nat. Cell Biol. 7,399-404 (2005). (Pubitemid 40533130)
20. Al-Khouri, A. M., Ma, Y., Togo, S. H., Williams, S. & Mustelin, T. Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta. J. Biol. Chem. 280,35195-35202 (2005). (Pubitemid 41532706)
21. Miller, S. J., Lou, D. Y., Seldin, D. C., Lane, W. S. & Neel, B. G. Direct identifi cation of PTEN phosphorylation sites. FEBS Lett. 528,145-153 (2002). (Pubitemid 35258015)
22. Torres, J. & Pulido, R. Th e tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276,993-998 (2001). (Pubitemid 32096519)
23. Waite, K. A. & Eng, C. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Hum. Mol. Genet. 12,679-684 (2003). (Pubitemid 36372494)
24. Shen, L. et al. SUMO protease SENP1 induces isomerization of the scissile peptide bond. Nat. Struct. Mol. Biol. 13,1069-1077 (2006). (Pubitemid 44885916)
25. Xu, Z. & Au, S. W. Mapping residues of SUMO precursors essential in diff erential maturation by SUMO-specifi c protease, SENP1. B iochem. J. 386,325-330 (2005). (Pubitemid 40343790)
26. Bayer, P. et al. Structure determination of the small ubiquitin-related modifi er SUMO-1. J. Mol. Biol. 280,275-286 (1998). (Pubitemid 28325519)
27. Eilebrecht, S., Smet-Nocca, C., Wieruszeski, J. M. & Benecke, A. SUMO-1 possesses DNA binding activity. BMC Res. Notes 3,146 (2010).
28. Liu, J. L. et al. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol. Cell Biol. 25,6211-6224 (2005).
29. Geiss-Friedlander, R. & Melchior, F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8,947-956 (2007). (Pubitemid 350176509)
30. Sumitomo, M. et al. Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. C ancer Cell 5,67-78 (2004). (Pubitemid 38121597)
31. Sobko, A., Ma, H. & Firtel, R. A. Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev. Cell 2,745-756 (2002). (Pubitemid 34650071)
32. Ross, A. H. & Gericke, A. Phosphorylation keeps PTEN phosphatase closed for business. P roc. Natl Acad. Sci. USA 106,1297-1298 (2009).
33. Iijima, M., Huang, Y. E., Luo, H. R., Vazquez, F. & Devreotes, P. N. Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis. J. Biol. Chem. 279,16606-16613 (2004). (Pubitemid 38509361)
34. Palm, D. et al. Th e norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int. J. Cancer 118,2744-2749 (2006). (Pubitemid 43673352)
35. Cheng, J., Kang, X., Zhang, S. & Yeh, E. T. SUMO-specifi c protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131,584-595 (2007). (Pubitemid 350007694)
36. Gruber, P. et al. Barbituric acid derivative BAS 02104951 inhibits PKCepsilon, PKCeta, PKCepsilon/RACK2 interaction, Elk-1 phosphorylation in HeLa and PKCepsilon and eta translocation in PC3 cells following TPA-induction. J. Biochem. 149,331-336 (2011).
37. van Loo, G. et al. Caspases are not localized in mitochondria during life or death. Cell Death Diff er. 9,1207-1211 (2002).
38. Janetopoulos, C., Borleis, J., Vazquez, F., Iijima, M. & Devreotes, P. Temporal and spatial regulation of phosphoinositide signaling mediates cytokinesis. Dev. Cell 8,467-477 (2005). (Pubitemid 40450737)
39. Ulrich, F. et al. Wnt11 functions in gastrulation by controlling cell cohesion through Rab5c and E-cadherin. Dev. Cell 9,555-564 (2005). (Pubitemid 41430738)
40. Wang, J., Cieplak, P. & Kollman, P. A. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem. 21,1049-1074 (2000).
41. Miyamoto, S. & Kollman, P. A. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13,952-962 (1992).